Kevin Ward, MD
Director
Weil Institute
Professor of Emergency Medicine and Professor of Biomedical Engineering
Medical School
[email protected]

Available to mentor

Kevin Ward, MD
Professor
  • About
  • Center Memberships
  • Recent Publications
  • Manage Your Profile
    About

    Dr. Ward is a Professor in the Departments of Emergency Medicine and Biomedical Engineering at the University of Michigan. He received his B.S. in Physiology from Louisiana State University in Baton Rouge in 1985 and his degree in medicine from Tulane University in New Orleans, LA in 1989. Dr. Ward then completed a residency in Emergency Medicine at the University of Pittsburgh followed by a Resuscitation Research fellowship at the Ohio State University in Columbus, OH. Prior to joining the University of Michigan in 2012, Dr. Ward was Professor and Associate Chair of Emergency Medicine at Virginia Commonwealth University (VCU) were he also founded and directed the VCU Reanimation Engineering Science Center (VCURES).

    Dr. Ward’s research interests span the field of critical illness and injury ranging from combat casualty care to the intensive care unit. His approach is to develop and leverage broad platform technologies capable of use throughout all echelons of care of the critically ill and injured as well as in all age groups. Dr. Ward’s work has been funded by the NIH, Department of Defense, NSF, and industry. He has published over 200 peer-reviewed articles and book chapters. He is the recipient of the Society of Academic Emergency Medicine’s Excellence in Research Award as well as the American College of Emergency Physicians Outstanding Contributions in Research Award.

    Dr. Ward’s passion is in creating programs which encourage true integration across the disciplines of medicine, engineering, data sciences, and entrepreneurship that accelerate discovery to true patient impact. In addition to founding the Max Harry Weil Institute for Critical Care Research and Innovation(link is external)(link is external), he led the design and implementation of Michigan Medicine’s Fast Forward Medical Innovation(link is external)(link is external) (FFMI) program and served as its inaugural Executive Director from 2013-2018. He is a serial innovator and entrepreneur in the field of emergency and critical care medicine and the recipient of Innovation and Commercialization awards from Virginia Commonwealth University, the University of Michigan Medical School, and the Department of Defense.

    In collaboration with the U.S. Army and its Joint Special Operations Training Medical Center, Dr. Ward developed and medically directed special training programs, which have been responsible for providing clinical training to over 1000 Special Operation Combat Medics. For this work, Dr. Ward was awarded a Certificate for Patriotic Civilian Service by the Department of the Army and the Joint Special Operations Training Center. Dr. Ward also served as a Lieutenant Colonel in the U.S. Army Medical Corps and its 948th Forward Resuscitation Surgical Team deploying to Afghanistan in support of Operation Freedom’s Sentinel and the 10th Special Forces Group (Airborne).

    Serving on numerous editorial and review boards in the field of resuscitation, emergency and critical care medicine, Dr. Ward also serves on the executive committee for the Trauma Hemostasis and Oxygenation Research (link is external) (link is external) (THOR).

    Administrative Contact:
    Denise Wieck
    [email protected]

    Center Memberships
    • Center Member
      Center for Computational Medicine and Bioinformatics
    Recent Publications See All Publications
    • Journal Article
      21 Optimizing AI-physician collaboration for enhanced diagnostic accuracy: A case study on acute respiratory distress syndrome detection using chest X-ray imaging
      Farzaneh N, Ansari S, Lee E, Ward KR, Sjoding MW. Journal of Clinical and Translational Science, 2025 Mar 28; 9 (s1): 7 - 8. DOI:10.1017/cts.2024.712
    • Proceeding / Abstract / Poster
      Project Nasal Photobiomodulation and Drug Delivery Device for TBI
      Nourmohammadi Z, Ward K, Zopf D. 2024 Oct 3;
    • Journal Article
      Use of a continuous single lead electrocardiogram analytic to predict patient deterioration requiring rapid response team activation
      Lee S, Benson B, Belle A, Medlin RP, Jerkins D, Goss F, Khanna AK, DeVita MA, Ward KR. PLOS Digital Health, 2024 Oct 1; 3 (10): DOI:10.1371/journal.pdig.0000465
    • Proceeding / Abstract / Poster
      Evaluating the Performance of Predictive Clinical AI/ML Tools After Deployment
      Baur B, Admon A, Cummings B, O’Brien C, Blackmer J, Ward K, Ansari S. 2024 May 7;
    • Proceeding / Abstract / Poster
      External Validation and Comparison of a General Ward Deterioration Index Between Diversely Different Health Systems
      Cummings B, O’Brien C, Blackmer J, Farzaneh N, Glassbrook J, Roebuck M, Sjoding M, Ward K, Ansari S. 2024 May 7;
    • Proceeding / Abstract / Poster
      Monitoring Dataset Shift in Clinical AI/ML Models during the Post-Deployment Phase (SAIL 2024 Spotlight Talk)
      O’Brien C, Admon A, Cummings B, Blackmer J, Ward K, Ansari S. 2024 May 7;
    • Proceeding / Abstract / Poster
      Development of an Ultrasound-based Flow-Pressure Index for the Assessment of Cerebrovascular Autoregulation
      Davis A, Dennis C, Sharpe Z, Greer N, Ward K, Tiba MH. 2024 Apr 10;
    • Proceeding / Abstract / Poster
      The Role of The Gut Microbiome in Traumatic Brain Injury
      Hernandez L, Sharpe Z, Greer N, Ward K, Tiba MH. 2024 Apr 10;
    Featured News & Stories A soldier tending to the wounds of a fellow soldier in the field
    Research News
    Weil Institute member to lead capstone training course for Special Operations Combat Medics
    Hurley Medical Center is one of only a handful of sites across the country recognized as an official partner site of the SOCM program. Weil Institute member Dr. Florian Schmitzberger was recently named Medical Director of the SOCM course at Hurley and speaks more about this unique military-civilian partnership and the changing landscape of combat casualty care.
    Clinician wearing medical gloves holds a patient's hand
    Research News
    How Weil grants benefit patients
    Weil leaders discuss the importance of research grants and what funding cuts could mean for patients.
    Nurse viewing AHI interface displayed on a laptop computer monitor.
    Research News
    Fifth Eye’s AHI-PI Demonstrates Ability to Detect Patient Deterioration Prior to Rapid Response Team Events: New Study Published in PLOS Digital Health
    Fifth Eye, Inc., a spin-off of the Max Harry Weil Institute for Critical Care Research and Innovation, announced the publication of a new study in the peer-reviewed journal, PLOS Digital Health, demonstrating the power of the company’s Analytic for Hemodynamic Instability-Predictive Indicator (AHI-PI) in predicting patient deterioration before a Rapid Response Team (RRT) event. An RRT event occurs when a dedicated team of healthcare professionals is mobilized to respond to a patient's critical deterioration. Detecting patient deterioration early is crucial, as it provides clinicians with more time to intervene, potentially preventing crises, improving patient outcomes, and reducing hospital costs.
    Close-up of multiple IV fluid bags in an operating room
    Research News
    U-M & Michigan Medicine collaboration addresses IV fluid shortage in less than 24 hours
    In a rapid response to the dire shortage of intravenous (IV) fluid bags currently affecting hospitals nationwide, investigators from the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation and U-M Precision Health have developed a novel projection model to help U-M Health teams conserve critical medical supplies.
    Illustration of the BioHelmet depicting clean air flowing in via the helmet's shroud and contaminated air flowing out through the attached HEPA filter and waist-mounted fan unit.
    Research News
    Weil Institute spin-off InspireRx awarded over $2 million for patient isolation system guarding against airborne infections
    InspireRx, LLC., a spin-off company of the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation, received over $2 million in Small Business Innovation Research (SBIR) grants to support further development of the AerosolVE BioHelmet, a compact negative pressure system for patients with highly contagious airborne respiratory infections such as COVID-19.
    Members of the Weil Institute Data Science and Commercialization teams stand at their table display during Celebrate Invention 2023.
    Research News
    Weil Institute to be Featured at 2024 Celebrate Invention!
    The Weil Institute will have a major presence at this year's Celebrate Invention event, hosted by U-M Innovation Partnerships. Dr. Kevin Ward, Executive Director of the Institute, will speak as the 2024 Distinguished University Innovator of the Year. Precision Trauma and RUA Diagnostics, two Weil Institute partners, will display a novel tourniquet and breath analysis technology, respectively.